Mostrando 10 resultados de: 18
Filtros aplicados
Publisher
International Journal of Molecular Sciences(5)
Current Pharmaceutical Design(2)
Advances in Pharmacological Sciences(1)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Current Diabetes Reviews(1)
Chronobiology and chronotherapy in depression: Current knowledge and chronotherapeutic promises
ArticleAbstract: Background: Depression is a heavily prevalent mental disorder. Symptoms of depression extend beyondPalabras claves:Agomelatine, Chronobiology, Chronodisruption, Chronotherapy, Depression, SleepAutores:Batista M.J., Cano-Ponce C., Chávez-Castillo M., Díaz E.A., González M.C., Ortega A., Pírela D., Riaño M., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusClinical-epidemiological analysis of hdl2 and hdl3 subfractions in adults from maracaibo city, venezuela
ArticleAbstract: Objective: To carry out a clinical-epidemiological analysis of high-density lipoprotein cholesterolPalabras claves:Cholesterol, HDL, Epidemiology (source: MeSH NLM), Lipoproteins, HDL2, Lipoproteins, HDL3, RISK FACTORSAutores:Alex Patricio Morales-Carrasco, Calvo M.J., González M.C., Linares S., Martínez M.S., Nava M., Olivar L.C., Ortega A., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusAdvanced glycation end products: New clinical and molecular perspectives
ArticleAbstract: Diabetes mellitus (DM) is considered one of the most massive epidemics of the twenty-first century dPalabras claves:Advanced glycation end products, Chronic complications, diabetes mellitus, Skin fluorescenceAutores:Cabrera M., Dávila L.C.A., D’marco L., González M.C., Hernández M., Morillo D., Nava M., Navarro C., Ortega A., Rina Ortiz, Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusDepression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusDepression as an immunometabolic disorder: Exploring shared pharma-cotherapeutics with cardiovascular disease
ReviewAbstract: Modern times have seen depression and cardiovascular disease (CVD) become notorious public health coPalabras claves:Cardiovascular disease, Chronic inflammation, Depression, Insulin Resistance, metabolism, Oxidative StressAutores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusElectroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications
ReviewAbstract: Electroconvulsive therapy (ECT) is based on conducting an electrical current through the brain to stPalabras claves:electroconvulsive therapy, hippocampus, mood disorders, neurogenesis, neuroinflammatory diseases, neurotransmitter agents, refractory depression, SchizophreniaAutores:Ariza D., Bautista M.J., Chávez-Castillo M., Medina-Ortiz O., Ortega A., Pérez J.L., Riaño-Garzón M.E., Rojas M., Rojas-Quintero J., Torres L.C., Valmore BermúdezFuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusMetabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
ReviewAbstract: The constant changes in cancer cell bioenergetics are widely known as metabolic repro-gramming. ReprPalabras claves:Carbohydrates, Energy metabolism, immunotherapy, inflammation, Metabolic reprogramming, neoplasms, tumor microenvironmentAutores:de Sanctis J.B., Galbán N., Garrido B., González M.C., Navarro C., Ortega A., Santeliz R., Valmore Bermúdez, Vera I.Fuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusPhytotherapy for cardiovascular disease: A bench-to-bedside approach
ReviewAbstract: At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality world-Palabras claves:atherosclerosis, Cardiovascular disease, dyslipidemia, Hypertension, Medicinal herbs, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Ortega A., Pírela D., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopus